Coagulopathy in COVID19

Yin, S., Huang, M., Li, D. et al. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis 51, 1107–1110 (2021).

  • COVID19 induced severe pneumonia patients demonstrate a much higher platelet count
  • Low molecular weight heparin is found to be beneficial only if D-dimer is markedly elevated in COVID19 induced severe pneumonia

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s